• SENSEX 80,599.91
    -585.67 (--0.72%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wanbury Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • PPI
  • BSE Code : 2393.0
  • ISIN : INE107F01022
268.45 0 (-0.17%)
  • As on 01 Aug 2025 (EOD)
  • Today’s Low

    260.00
  • Today’s High

    272.00
  • Open

    266.00
  • Perv Close

    268.90
  • 52W Low

    154.01
  • 52W High

    329.70

Key Indicators

  • P/E(TTM)

    29.04

  • Mar.Cap (₹Cr.)

    882.58

  • Div & Yield %

    0.00

  • Book Value(₹)

    18.06

  • Debt-Equity Ratio

    -0.17

  • AGM Date

    01-Aug-2025

  • EPS

    9.29

  • P/E Ratio

    29.04

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    882.58

  • RONW (%)

    49.77

  • ROCE (%)

    33.46

Score Board

  • Equity (₹ in Cr.)

    32.88

  • BV (₹)

    18.10

  • Sales( ₹ in Cr.)

    599.51

  • NP (in Cr.)

    30.53

  • NP Var(%)

    2.0

  • Div%

    0.0

  • CPS (₹)

    13.30

  • EPS (₹)

    9.30

  • Traded Value (₹ in Lakhs)

    886.86

  • 52 Week High

    329.70

  • 52 Week Low

    154.01

  • Price BSE

    270.0

  • Price NSE

    268.00

  • Market Capital( in Cr.)

    886.86

  • P/C Ratio

    20.20

  • P/E Ratio

    29.10

  • Price Vs.BV

    9.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 575.65 499.65 511.19 392.52 367.45 391.37
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 575.65 499.65 511.19 392.52 367.45 391.37
Other Income 2.99 0.91 77.88 2.40 83.78 9.33
Stock Adjustments 3.89 -29.13 24.79 7.20 -5.99 5.06
Total Income 582.53 471.43 613.86 402.12 445.24 405.76
EXPENDITURE :            
Raw Materials 306.52 274.31 325.07 228.53 169.75 201.26
Power and Fuel Cost 24.58 20.59 18.41 17.13 15.38 14.46
Employee Cost 86.92 81.00 74.81 64.15 67.48 75.89
Other Manufacturing Expenses 13.32 11.43 12.66 9.98 13.77 7.98
Selling and Administration Expenses 58.51 45.16 55.34 45.49 55.36 63.70
Miscellaneous Expenses 19.69 15.45 14.36 16.42 16.29 17.59
Employee Benefit Expenses 86.92 81.00 74.81 64.15 67.48 75.89
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 509.54 447.94 500.65 381.70 338.02 380.89
Operating Profit 72.99 23.49 113.19 20.42 107.23 24.86
Interest 29.18 21.39 20.61 23.07 32.87 39.88
Gross Profit 43.81 2.10 92.58 -2.65 74.36 -15.02
Depreciation 13.03 12.38 11.45 9.75 9.68 9.97
Profit Before Tax 30.78 -10.28 81.13 -12.40 64.68 -24.99
Current Tax 0.00 0.00 0.00 2.27 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.38 0.11 -0.35 -2.07 0.21 -0.14
Reported Net Profit 30.40 -10.40 81.47 -12.61 64.46 -24.85
Extraordinary Items 0.49 -0.31 76.06 1.21 82.62 0.12
Adjusted Net Profit 29.91 -10.09 5.41 -13.82 -18.16 -24.97
Adjustment below Net Profit -0.59 0.26 0.80 -0.44 -0.46 0.31
P & L Balance brought forward -168.14 -158.01 -240.28 -227.23 -291.23 -266.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -138.34 -168.14 -158.01 -240.28 -227.23 -291.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.28 -3.18 24.94 -5.04 25.79 -10.48
Earnings Per Share(Adj)-Unit Curr 9.28 -3.18 24.94 -5.04 25.79 -10.48
Book Value 6.70 -2.26 0.57 -52.23 -47.14 -77.40
Book Value(Adj)-Unit Curr 6.70 -2.26 0.57 -52.23 -47.14 -77.40

Shareholding Pattern

  • Promoter Group

    39.63%

  • Public Share Holding

    60.37%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 3,024,000 9.20 3,024,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,024,000 9.20 3,024,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,005,561 30.43 10,005,561 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,005,561 30.43 10,005,561 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 521 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 522,261 1.59 522,261 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 66 0.00 66 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 522,848 1.59 522,327 9
2] Non Institution
Bodies Corporate 2,705,206 8.23 2,704,003 169
Clearing Members 109,271 0.33 109,271 37
Directors of their Relatives 0 0.00 0 0
Employees 234,320 0.71 211,820 3
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 485,275 1.48 483,156 230
Foreign Non Institution Other 94,680 0.29 0 1
Hindu Undivided Families 946,702 2.88 946,636 540
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,512,636 19.81 6,512,636 96
Individuals holding nominal share capital up to Rs. 1 lakh 7,316,944 22.26 7,111,443 16,779
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 356,465 1.08 352,715 3
Sub Total 19,324,589 58.78 18,994,770 17,883
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 32,876,998 100.00 32,546,658 17,894

Company Background

Wanbury LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wanbury Ltd
  • BSE Code : 2393.0
  • ISIN : INE107F01022
  • Incorporation Year

    1988

  • Registered Office

    BSEL Tech Park B-Wing 10th Flr
    Sector 30 A Opp Vashi Rly Stat, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-67942222

  • FAX

    91-22-67942111/333

  • Chairman

    K Chandran

  • Managing Director

  • Company Secretary

    Jitendra J Gandhi

  • Auditor

    V Parekh & Associates/Kapoor & Parekh Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    Unit No 1 Luthra Ind,
    Andheri Kurla Road ,Safed Pool Andheri(E
    Mumbai - Mumbai - 400 072

Wanbury Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wanbury 269.75 578.64 575.65 29.04 32.14
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10